Viewing nowNexpazole Tablet 20 mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

MFDS item code 201508512 · Approved 2015.12.30 · Insurance code 671704880
Treatment and prevention of acid-related disorders (such as reflux and ulcers), Helicobacter pylori eradication, and gastrointestinal disorders caused by anti-inflammatory drugs
This medication is used for long-term maintenance therapy to treat gastroesophageal reflux disease, particularly erosive esophagitis and to prevent its recurrence. It is also effective in the eradication of Helicobacter pylori when used in combination with antibiotics for the treatment of Helicobacter pylori-positive peptic ulcers and duodenal ulcers. It helps to treat upper gastrointestinal symptoms due to the use of non-steroidal anti-inflammatory drugs as well as preventing gastric ulcers and duodenal ulcers related to non-steroidal anti-inflammatory drug use. It is also used in the treatment of Zollinger-Ellison syndrome and maintenance therapy to prevent rebleeding from gastric ulcers or duodenal ulcers. Thus, it is widely utilized for the treatment of various gastrointestinal disorders and improves patient symptoms.
This medication should be swallowed with a liquid such as water and should not be chewed or crushed. Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medication for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent recurring symptoms are controlled by administering 20 mg once daily. Symptomatic treatment of gastroesophageal reflux disease without esophagitis: In adults, 20 mg may be taken once daily as needed. As-needed administration is not recommended to control recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. Administer this medication 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical studies exceeding 4 weeks have not been conducted. Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into 2 doses. Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration. No dose adjustment is necessary. Since there is limited experience administering this medication to patients with severe renal failure, it should be used with caution. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medication should not exceed 20 mg. No dose adjustment is necessary.
Adolescents 12 years of age and older — Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take the medication for an additional 4 weeks. Adolescents 12 years of age and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents 12 years of age and older — Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent recurring symptoms are controlled by administering 20 mg once daily. Children under 12 years of age: There is no experience with administration of this medication to children under 12 years of age.
This medication should not be used in patients with hypersensitivity to specific ingredients or benzimidazole derivatives, or those who have experienced such reactions in the past. Patients with allergies to penicillin-type antibiotics or macrolide antibiotics should also exercise caution, especially when used in combination for the eradication of Helicobacter pylori. Furthermore, patients who are taking some cardiac-related medications or antivirals, as well as those who are nursing or have a history of myocardial infarction, should not use this medication. This medication contains a dye called Yellow No. 5, so patients with allergies or sensitivity to this ingredient should be careful. During use, various side effects such as rare blood-related abnormal symptoms or allergic reactions, electrolyte imbalance, mental changes, headaches, gastrointestinal issues may occur, so immediate consultation with healthcare professionals is necessary if such symptoms arise. It is important to undergo regular examinations to check for abnormalities during long-term use. This medication suppresses gastric acid secretion and may promote bacterial growth in the stomach, which can increase the risk of certain bacterial infections. Additionally, long-term use may increase the risk of fractures, so patients at risk for osteoporosis should exercise caution. Magnesium levels may decrease, so patients taking this medication long-term should periodically check their blood magnesium concentration. Due to potential drug interactions, there may be changes in drug concentration or the risk of side effects when used in combination with other medications, so it is essential to inform healthcare professionals about all medications being taken. During pregnancy, safety has not been sufficiently established; it should be used cautiously only when necessary, and it is advisable not to take this medication during breastfeeding. In case of overdose, there is no specific antidote, and appropriate treatment should be conducted based on symptoms, and it should be kept out of reach of children.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylaxis, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, dysgeusia, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, xerostomia, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, pruritus, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucosal erythema syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, acute generalized pustular psoriasis, drug response with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, fatigue, increased sweating, Clostridium difficile diarrhea, abdominal bloating, allergic reaction, back pain, chest pain, substernal chest pain, facial swelling, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid gland swelling, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal malformation, upper abdominal pain, belching, esophageal disorders, frequent bowel movements, gastritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, earache, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, convulsions, fibromyalgia syndrome, hernia, inflammatory polymyalgia rheumatica, anorexia, apathy, increased appetite, confusion, exacerbation of depression, hypertonia, sensory impairment, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorder, tremor, visual field defect, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal pruritus, erythematous rash, papular rash, otitis media, altered olfaction, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urination frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to protect it from exposure to air or moisture. It is also safest to store it at a cool room temperature between 1 degree and 30 degrees.
Pale pink oval film-coated tablet
28 tablets (14 tablets/Alu-Alu * 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.